Orchestra BioMed
Price & Volume
Stats
See moreOpen | $4.81 |
Previous Close | $4.72 |
Day Range | $4.76-$4.88 |
52W Range | $3.96-$8.87 |
Market Cap | $179.4M |
Shares Short | 474,000 |
Financials
See moreRevenue (12 Mos) | $2.6M |
Revenue Growth (YoY) | 135.6% |
Gross Profit (12 Mos) | $2.4M |
Diluted EPS | -$1.60 |
News
See moreYahoo Finance • 6 days ago
Orchestra BioMed Appoints Vivek Reddy, M.D. as Executive Chairman of the BACKBEAT Study Steering Committee and Chairman of Bioelectronic Therapies Scientific Advisory Board
Yahoo Finance • 12 days ago
Orchestra BioMed Announces Data Demonstrating Favorable Impact of AVIM Therapy on Diastolic Dysfunction, a Key Driver of Heart Failure Progression, will be Presented as Late-Breaking Science at the THT 2025 Conference
Yahoo Finance • 19 days ago
Orchestra BioMed Announces Appointment of Former Medtronic SVP of Corporate Development Christopher Cleary to Board of Directors
Yahoo Finance • last year
Orchestra BioMed Reports Third Quarter 2023 Financial Results and Provides Business Update
About
CEO | Mr. David P. Hochman |
Address | 150 Union Square Drive, New Hope, PA, United States, 18938 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 56 |
